BridgeMD
New treatment option for Chronic Fatigue Syndrome
Official title Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue
ClinicalTrials.gov ID: NCT06170645
What this study is testing
- What it's testing
- Chronic fatigue is enhanced by adapted physical activity (APA) programs. Patients consulting on St Etienne hospital and suffering from fibromyalgia and long Covid benefit from a 4-6 week APA program, with 2 sessions per week.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 years old
- Signature of informed consent
- Confirmed diagnosis of fibromyalgia or long Covid (ACR 2016 criteria and persistent symptoms lasting more than 6 months after a positive RT-PCR test...
- Persistent fatigue after an exercise rehabilitation program (FSS score \> 36)
- Physical inactivity, i.e. \<150 minutes per week of physical activity
You likely can't join if
- Pre-existing atrial fibrillation,
- Left ventricular ejection fraction \<40%
- Severe heart failure
- Recent stroke or myocardial infarction (\<6 months)
- Unilateral or bilateral vagotomy
- Pregnancy or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Etienne, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Etienne, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.